Defendant Name: Robert O. Hopkins

Defendant Type: Individual

Initial Case Details

Legal Case Name In the Matter of DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation) and Robert O. Hopkins
First Document Date 14-Jan-2025
Initial Filing Format Administrative Action
File Number 3-22416
Allegation Type Issuer Reporting and Disclosure

Affiliations

Violations Alleged

Exchange Act
• Sec 10(b) + Rule 10b-5
• Rule 13a-14
• Sec 13(b)(5)
Securities Act
• Sec 17(a)(1)
• Sec 17(a)(3)
Other
• Rules 13b2-1, 13b2-2 Exchange Act

Related Violations Alleged

Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Rule 12b-20 of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Sec 13(a) of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Rule 13a-1 of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Rule 13a-13 of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Sec 13(b)(2)(B) of the Exchange Act.
Robert O. Hopkins is alleged to have caused DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)'s violation of Sec 17(a)(2) of the Securities Act.

Resolutions

Bars:
First Resolution Date 14-Jan-2025

Related Documents:

33-11353 14-Jan-2025 Administrative Proceeding
Order Instituting Administrative and Cease-and-Desist Proceedings, Pursuant to Section 8A of the Securities Act of 1933, Sections 4C and 21C of the Securities Exchange Act of 1934, and Rule 102(e) of the Commission's Rules of Practice, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order

Other Defendants in Action:

DMK Pharmaceuticals Corporation (f/k/a Adamis Pharmaceuticals Corporation)